AI Article Synopsis
- - The study aimed to verify the pathogenicity of uncertain genetic variants in newborns utilizing mass spectrometry and analysis, involving 3,071 participants across 35 centers.
- - Results indicated that 68.15% of subjects carried variants of uncertain significance (VUS), with those having pathogenic variants showing significantly higher levels of specific metabolites compared to non-variant groups.
- - The findings suggest that elevated metabolic biomarkers in VUS cases could indicate a likely pathogenic status, implying that mass spectrometry and analysis are promising methods for studying these genetic variants.
Article Abstract
Objective: To accurately verify the pathogenicity of variants of uncertain significance (VUS) in and genes through mass spectrometry and analysis.
Methods: This multicenter retrospective study included 35 participating units (ClinicalTrials.gov ID: NCT06183138). A total of 3,071 newborns (within 7 days of birth) were sorted into carrying pathogenic/likely pathogenic (P/LP) variants and carrying VUS, non-variant groups. Differences in metabolites among the groups were calculated using statistical analyses. Changes in conservatism, free energy, and interaction force of and variants were analyzed using analysis.
Results: The percentage of those carrying VUS cases was 68.15% (659/967). In the gene variant, we found that C3, C3/C2, and C3/C0 levels in those carrying the P/LP variant group were higher than those in the non-variant group ( < 0.000). The conservative scores of those carrying the P/LP variant group were >7. C3, C3/C0, and C3/C2 values of newborns carrying VUS (c.1159A>C and c.1286A>G) were significantly higher than those of the non-variant group and the remaining VUS newborns ( < 0.005). The conservative scores of c.1159A>C and c.1286A>G calculated by ConSurf analysis were 9 and 7, respectively. Unfortunately, three MMA patients with c.1159A>C died during the neonatal period; their C3, C3/C0, C3/C2, and MMA levels were significantly higher than those of the controls.
Conclusion: Common variants of methylmalonic acidemia in the study population were categorized as VUS. In the neonatal period, the metabolic biomarkers of those carrying the P/LP variant group of the gene were significantly higher than those in the non-variant group. If the metabolic biomarkers of those carrying VUS are also significantly increased, combined with analysis the VUS may be elevated to a likely pathogenic variant. The results also suggest that mass spectrometry and analysis may be feasible screening methods for verifying the pathogenicity of VUS in other inherited metabolic diseases.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11284102 | PMC |
| http://dx.doi.org/10.3389/fgene.2024.1403913 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multigene Panel Testing Revealed Novel Variants in Hereditary Spherocytosis Patients in Türkiye.
Turk J Haematol
January 2025
Marmara University Faculty of Medicine, Department of Medical Genetics, İstanbul, Türkiye.
Objective: This study aims to determine the genotypic characteristics of Hereditary Spherocytosis (HS) patients in Turkiye and to examine the correlation between genotype and phenotype.
Materials And Methods: Herein we had 18 patients who were admitted to pediatric hematology outpatient clinic with hemolytic anemia, jaundice, cholelithiasis, and splenomegaly. According to the Eber's classification, the patients' clinical presentations were categorized as mild, moderate, and severe.
Molecular genetics in adult-onset Still's disease: next-generation sequencing in 24 patients and literature review.
Front Immunol
November 2024
Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Objective: Next-generation sequencing (NGS) panels are increasingly used for the diagnosis of monogenic systemic autoinflammatory diseases (SAIDs). However, their role in patients with adult-onset Still's disease (AOSD) remains unknown. This study aims to assess the usefulness of NGS panels in AOSD patients to improve diagnosis and management of the disease.
View Article and Find Full Text PDFLong-read sequencing enables comprehensive molecular genetic diagnosis of Fabry disease.
Hum Genomics
November 2024
Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Background: The clinical diagnosis of Fabry Disease (FD) can be challenging due to the clinical heterogeneity, especially in females. Patients with FD often experience a prolonged interval between the onset of symptoms and receiving a diagnosis. Genetic testing is the gold standard for precise diagnosis of FD, however conventional genetic testing could miss deep intronic variants and large deletions or duplications.
View Article and Find Full Text PDFThree Iranian patients with rare subtypes of hereditary spastic paraplegia (HSP): SPG76, SPG56, and SPG69.
Neurogenetics
November 2024
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Some subtypes of hereditary spastic paraplegia (HSP), especially with autosomal recessive inheritance (AR-HSP), have been reported rarely. In this study, we report the clinical features and molecular results of three unrelated Iranian patients with rare subtypes of HSP, including SPG76, SPG56, and SPG69; thereafter, we compare them to other reported cases. Three patients who were clinically diagnosed with HSP and born to consanguineous parents underwent molecular assessment by whole-exome sequencing (WES), followed by Sanger sequencing and co-segregation analysis.
View Article and Find Full Text PDFRetinitis Pigmentosa Associated With EYS Gene Mutations in Puerto Rico: A Case Series.
Cureus
October 2024
Department of Surgery, University of Puerto Rico, Medical Sciences Campus, San Juan, PRI.
Background: Mutations in the (eyes shut homolog) gene are a known cause of autosomal recessive retinitis pigmentosa (arRP). Pathogenic variants in have been associated with a more severe clinical course compared to mutations in other retinitis pigmentosa (RP)-related genes. The prevalence of -related arRP varies among different populations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!